CrossrefInfokarte
Efficacy of continuous ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia with high-burden and low-burden TP53 mutations: Multicenter retrospective analysis of the Polish Adult Leukemia Group (PALG)
Advances in Clinical and Experimental Medicine · 2026-10-15 · 35 (10) · 1725-1734
DOI: 10.17219/acem/215822 ↗Abstract
Kein Abstract verfügbar.
EUVIMED